That would be a marked change from the past year, which prioritized rhetoric and politics over an evidence-based understanding of the health care value chain and the challenges patients face at the pharmacy counter.
At the National Pharmaceutical Council, this year we intend to play a significant role in fostering a much more informed, evidence-based dialogue. Through our health policy research and partnerships, we will focus significant time on examining and explaining the true cost of prescription drugs and the value they provide. We also want to bring about a much greater understanding of the health care value chain, including the sometimes-perplexing incentives that can distort the most important parts of health care delivery.
Read Full Article »